Right now, only one company is trying to develop a new type of cell therapy for cancer: Iovance Biotherapeutics, with a market cap of $1.3 billion and 80 employees, and $246 million in the bank.

As healthcare organizations move from fee-for-service to value-based care, telehealth can enable the delivery of medicine at every point in the care continuum, according to a new infographic by InTouch Health. The infographic provides a roadmap to help navigate the telehealth landscape. Artificial intelligence. Automation. Blockchain. Robotics. Once the domain of science fiction, these teleheal...